Hereditary Vitamin D Resistant Rickets (HVDRR) Case Series: Phenotype, Genotype, Conventional Treatment, and Adjunctive Cinacalcet Therapy

    Noman Ahmad, Sundus A. Ansari, Nabil Abdulrahman Aleysae, Emily L. G. Heaphy, Mrouge Mohamed Sobaihi, Balgees Alghamdi, Ali S. Alzahrani
    Image of study
    TLDR Cinacalcet may help treat hereditary vitamin D resistant rickets safely.
    This study examined 8 patients with hereditary vitamin D resistant rickets (HVDRR) from 5 Saudi families, all of whom exhibited alopecia and secondary hyperparathyroidism. Genetic analysis identified 3 distinct mutations in the vitamin D receptor gene. Four patients were treated with high-dose calcium alone, while the other 4 received additional cinacalcet, a calcimimetic. The use of cinacalcet showed promise in improving serum PTH levels without causing hypocalcaemia, suggesting it may be a safe and valuable adjunctive therapy. However, the response to treatment varied, and further research is needed to confirm these findings.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results